Nuveen Asset Management’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$1.96M Sell
131,859
-37,994
-22% -$566K ﹤0.01% 2398
2024
Q3
$2.6M Buy
169,853
+2,552
+2% +$39K ﹤0.01% 2294
2024
Q2
$2.55M Buy
167,301
+40,082
+32% +$610K ﹤0.01% 2266
2024
Q1
$2.4M Sell
127,219
-6,228
-5% -$118K ﹤0.01% 2312
2023
Q4
$2.55M Sell
133,447
-330,476
-71% -$6.31M ﹤0.01% 2301
2023
Q3
$8.33M Buy
463,923
+5,780
+1% +$104K ﹤0.01% 1583
2023
Q2
$9.3M Buy
458,143
+16,902
+4% +$343K ﹤0.01% 1557
2023
Q1
$8.05M Buy
441,241
+298,925
+210% +$5.45M ﹤0.01% 1622
2022
Q4
$2.94M Sell
142,316
-24,359
-15% -$504K ﹤0.01% 2205
2022
Q3
$4.36M Sell
166,675
-4,956
-3% -$130K ﹤0.01% 1981
2022
Q2
$4.35M Sell
171,631
-86,371
-33% -$2.19M ﹤0.01% 2036
2022
Q1
$8.93M Sell
258,002
-1,224
-0.5% -$42.4K ﹤0.01% 1720
2021
Q4
$10.1M Sell
259,226
-18,817
-7% -$731K ﹤0.01% 1688
2021
Q3
$10.1M Sell
278,043
-147,031
-35% -$5.35M ﹤0.01% 1773
2021
Q2
$11.7M Buy
425,074
+253,089
+147% +$6.95M ﹤0.01% 1771
2021
Q1
$4.83M Sell
171,985
-32,804
-16% -$921K ﹤0.01% 2187
2020
Q4
$5.32M Sell
204,789
-11,563
-5% -$300K ﹤0.01% 2042
2020
Q3
$3.71M Sell
216,352
-65,075
-23% -$1.12M ﹤0.01% 2077
2020
Q2
$6.96M Buy
281,427
+45,307
+19% +$1.12M ﹤0.01% 1715
2020
Q1
$3.28M Buy
236,120
+49,958
+27% +$694K ﹤0.01% 1937
2019
Q4
$1.88M Buy
186,162
+45,707
+33% +$462K ﹤0.01% 2441
2019
Q3
$1.28M Buy
140,455
+6,962
+5% +$63.3K ﹤0.01% 2593
2019
Q2
$1.06M Buy
+133,493
New +$1.06M ﹤0.01% 2705